Wentao Tian

5PUBLICATIONS
6CO-AUTHORS
Chinese languagesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 06, 2025
Response to Zhang, Wang, Li, et al.

Xianjing Chu, Wentao Tian, Rongrong Zhou

|Aug 29, 2024
Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer.

Wentao Tian, Lishui Niu, Rongrong Zhou

|Jun 03, 2024
First-line treatments for advanced non-squamous non-small cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a systematic review, network meta-analysis, and cost-effectiveness analysis.

Wentao Tian, Lishui Niu, Yin Shi

|Jun 13, 2022
Adjuvant EGFR tyrosine kinase inhibitors for patients with resected EGFR-mutated non-small-cell lung cancer: a network meta-analysis.

Wentao Tian, Nuopei Tan, Jiawen Ke

|Dec 02, 2020
Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer.

Wentao Tian, Chenghui Cao, Long Shu

Pageof 1

Frequent Collaborators

3 joint publications

Rongrong Zhou

2 joint publications

Fang Wu

1 joint publications

Nuopei Tan

1 joint publications

Jiawen Ke